State Ledger
Company profile

Zentalis Pharmaceuticals, Inc. CIK 1725160

Ticker
ZNTL (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92121
Fiscal year end
2025 (FY)
Market Data
Close
$2.64
Change
+$0.14
Change %
5.60%
Volume
41,408

ZNTL · trading date Oct 9, 2026 · previous close $2.50 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$137.06M
Total assets
$288.97M
Total liabilities
$72.76M
Stockholders' equity
$216.20M
Cash & equivalents
$36.00M
Operating income
-$152.81M
Operating cash flow
-$125.25M
Capital expenditures
$0

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$125.25M
Free cash flow margin
—
Liabilities / assets
25.2%
Equity / assets
74.8%
CapEx / revenue
—
Operating cash flow / net income
0.91×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$137.06M $288.97M $72.76M $216.20M
2024 $67.43M -$165.84M $430.34M $93.15M $337.19M
2023 $0 -$292.19M $551.69M $114.30M $437.28M
2022 $0 -$236.81M $539.31M $105.29M $433.80M
2021 — -$158.73M $454.51M $90.03M $364.48M
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G/A
2026-08-19
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92121
10275 SCIENCE CENTER DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies